Palvella Therapeutics, Inc
PVLA
$150.56-2.44%
End of day · as of Sep 19, 2026, 5:00 PM ET
Mkt cap
$1.64B
EV/Sales
36.9
P/E ratio
N/A
FY2023 Revenue
$42.81M
EPS (H1 2026)
$-2.74
Gross Margin (FY2023)
N/A
Profit Margin (FY2023)
-57.33%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Palvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
Latest reported PVLA revenue for 2023-12-31 was $42.8M. Net income was -$24.5M. Revenue was up 65.3% from 2022-12-31 to 2023-12-31. PVLA currently screens at market cap $1.64B.
Use this PVLA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PVLA income, balance, and cash tables.
Palvella Therapeutics, Inc (PVLA) is a biotechnology company in the Healthcare sector.
Latest cached Palvella Therapeutics, Inc (PVLA) revenue for Dec 31, 2023 was $42.8M. Net income was -$24.5M. Statements: https://lician.com/financials/pvla
Palvella Therapeutics, Inc (PVLA) market capitalization is $1.64B on the latest cached snapshot.
Palvella Therapeutics, Inc (PVLA) cached previous close $154.32; day range $149.20 – $154.72; volume 633,490. Session quote: https://lician.com/quote/pvla
Palvella Therapeutics, Inc (PVLA) latest cached earnings event is "PVLA earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PVLA filing is 8-K · Aug 4, 2026. Filings: https://lician.com/sec/pvla